Gene · 4880
Papers1,757
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 1,757
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Cardiorenal Syndrome: Challenges in Everyday Clinical Practice and Key Points towards a Better Management. | J Clin Med | 2023 | 37373813 | PubTator, text mining | PubMed |
| Bone Growth Induction in Mucopolysaccharidosis IVA Mouse. | Int J Mol Sci | 2023 | 37373036 | PubTator, text mining | PubMed |
| Bioinspired Oligo-Urethane Nanoparticles for Delivering Exogenous C-Type Natriuretic Peptide: Synthetic Biomaterial Nanocarrier Complexes and Their Interactions with Cardiac Myofibroblasts. | Biomacromolecules | 2023 | 37344353 | PubTator, text mining | PubMed |
| C-Type Natriuretic Peptide in Essential Hypertension: Old Ways for a New Time. | JACC Basic Transl Sci | 2023 | 37325397 | PubTator, text mining | PubMed |
| The Natriuretic Peptide System: A Single Entity, Pleiotropic Effects. | Int J Mol Sci | 2023 | 37298592 | PubTator, text mining | PubMed |
| The Role of the Cardiac Biomarkers in the Renal Cell Carcinoma Multidisciplinary Management. | Diagnostics (Basel) | 2023 | 37296764 | PubTator, text mining | PubMed |
| A comprehensive review of acute cardio-renal syndrome: need for novel biomarkers. | Front Pharmacol | 2023 | 37288107 | PubTator, text mining | PubMed |
| Synthetic Phenolic Antioxidants and Their Metabolites in Follicular Fluid and Association with Diminished Ovarian Reserve: A Case-Control Study. | Environ Health Perspect | 2023 | 37267061 | PubTator, text mining | PubMed |
| Exercise, exerkines, and cardiometabolic health: from individual players to a team sport. | J Clin Invest | 2023 | 37259917 | PubTator, text mining | PubMed |
| How to Use Natriuretic Peptides in Patients with Heart Failure with Non-Reduced Ejection Fraction? | Anatol J Cardiol | 2023 | 37257015 | PubTator, text mining | PubMed |
| Prospects for fertility preservation: the ovarian organ function reconstruction techniques for oogenesis, growth and maturation in vitro. | Front Physiol | 2023 | 37250136 | PubTator, text mining | PubMed |
| Advances in Oocyte Maturation In Vivo and In Vitro in Mammals. | Int J Mol Sci | 2023 | 37240406 | PubTator, text mining | PubMed |
| Therapeutic Peptides for Treatment of Lung Diseases: Infection, Fibrosis, and Cancer. | Int J Mol Sci | 2023 | 37239989 | PubTator, text mining | PubMed |
| Evidence for Angiotensin II as a Naturally Existing Suppressor for the Guanylyl Cyclase A Receptor and Cyclic GMP Generation. | Int J Mol Sci | 2023 | 37239899 | PubTator, text mining | PubMed |
| A Combination of an Angiotensin II Receptor and a Neprilysin Inhibitor Attenuates Liver Fibrosis by Preventing Hepatic Stellate Cell Activation. | Biomedicines | 2023 | 37238965 | PubTator, text mining | PubMed |
| Exploring Toxin Genes of Myanmar Russell's Viper, Daboia siamensis, through De Novo Venom Gland Transcriptomics. | Toxins (Basel) | 2023 | 37235344 | PubTator, text mining | PubMed |
| Deep Proteomics Network and Machine Learning Analysis of Human Cerebrospinal Fluid in Japanese Encephalitis Virus Infection. | J Proteome Res | 2023 | 37219084 | PubTator, text mining | PubMed |
| Estimation of GCF and Salivary Levels of NT-proBNP in Systemically Healthy Subjects with Severe Chronic Periodontitis Before and After Periodontal Flap Surgery. | Int J Gen Med | 2023 | 37213473 | PubTator, text mining | PubMed |
| Resveratrol-Induced Suppression of C-type Natriuretic Peptide Associates With Increased Vertebral Bone Density in Postmenopausal Women. | JBMR Plus | 2023 | 37197320 | PubTator, text mining | PubMed |
| A Case of Fibula Regeneration after Below-the-knee Amputation in an Adult. | Plast Reconstr Surg Glob Open | 2023 | 37180983 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4880/papers?page=9